The results from the subgroup analyses showed that no prognostic superiority was observed for IPC in tumour grade, LN status, ER status or PR status subgroups, suggesting that the differences observed in survival outcomes between IPC and IDC resulted primarily from the distributions of tumour grades, LN statuses, and ER and PR statuses in the 2 tumour types. This evidence concerns the gene PGR and neoplasm.